Stryker Corporation

New York Stock Exchange
Back to all articles
Slightly Bullish +15

Stryker stock steadies after target cuts and earnings gains

Analyst downgrade Earnings report AI-generated analysis

📈 Stryker Corp. reported second-quarter 2026 revenue of USD 6.59 billion, representing a 9.4 percent increase year-over-year.

💰 Adjusted earnings per share reached USD 3.69, surpassing the USD 3.49 consensus estimate by USD 0.20.

📉 TD Cowen lowered its price target to USD 298 from USD 355 while maintaining a Hold rating on Stryker stock.

🔼 Wolfe Research raised its price target to USD 375 following the company's strong second-quarter financial results.

⚠️ Citizens cut its price target to USD 400 due to concerns over operational disruptions including a cyberattack and supply-chain issues.

📊 Stryker provided fiscal 2026 earnings guidance of USD 14.950 to USD 15.100 per share, indicating future profitability expectations.

📉 The stock closed at USD 275.09 on September 22, 2026, after a daily gain of 0.33 percent despite mixed analyst sentiment.

💸 Stryker's market capitalization is valued at USD 106.14 billion as of the September 22, 2026 close.

📉 The stock has declined 21.6 percent year-to-date, highlighting a gap between operational growth and current valuation sentiment.

Bullish Signals
  • Stryker Corp. achieved second-quarter 2026 revenue of USD 6.59 billion, marking a 9.4 percent increase compared to the prior-year period.
  • The company delivered adjusted earnings per share of USD 3.69, which exceeded the analyst consensus estimate by USD 0.20.
  • Wolfe Research raised its price target to USD 375 in response to Stryker's strong second-quarter financial performance.
  • Management provided fiscal 2026 earnings guidance of USD 14.950 to USD 15.100 per share, signaling confidence in future profitability.
Risk Factors
  • TD Cowen lowered its price target from USD 355 to USD 298 while retaining a Hold rating on Stryker stock.
  • Citizens cut its price target to USD 400 due to concerns regarding operational disruptions, including a cyberattack and supply-chain issues.
  • Investors are weighing Stryker's growth against potential gross-margin pressure and manufacturing disruptions affecting the company.
Full Analysis
Stryker Corp. reported second-quarter 2026 results showing revenue growth of 9.4 percent to USD 6.59 billion, with adjusted earnings per share reaching USD 3.69, beating the consensus estimate by USD 0.20. The company's stock closed at USD 275.09 on September 22, 2026, reflecting a modest gain despite mixed analyst reactions following the earnings release. Market sentiment around Stryker remains divided as major investment banks revise their price targets. TD Cowen lowered its target to USD 298 citing operational disruptions, while Wolfe Research raised its target to USD 375 based on strong quarterly performance. Citizens cut its target to USD 400 due to concerns over a cyberattack and supply-chain issues. The divergence in analyst views highlights the tension between Stryker's solid operating growth and headwinds regarding gross margins and manufacturing stability. Management provided fiscal 2026 earnings guidance ranging from USD 14.950 to USD 15.100 per share, offering a forward-looking counterweight to the lower valuation targets set by some analysts. Stryker's market capitalization stands at USD 106.14 billion as of September 22, 2026. While the stock has underperformed year-to-date with a decline of 21.6 percent, the recent earnings beat suggests that operational execution remains robust despite external pressures affecting investor confidence.